A Study of TAK-881 With and Without Ramp-Up Dosing in Healthy Adults

NCT06935266 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
64
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Takeda